What is Evommune 's interest paid?

Evommune (EVMN) reported interest paid of $19.47K in Q1 2026.

What does interest paid mean?

Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.

Evommune EVMN Interest Paid

Interest Paid at other companies

PfizerPFE

$293M-17.0%

BillionToOne, Inc. BLLN

$1.49M+11.8%

Hims & Hers HealthHIMS

——

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's interest paid?: Evommune (EVMN) reported interest paid of $19.47K in Q1 2026.
What does interest paid mean?: Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.